乙酰肝素酶在乳腺浸润性导管癌中的表达及其意义

    Expression of heparanase in invasive ductal carcinomas of the breast and its significance

    • 摘要: 目的:探讨乙酰肝素酶(Hpa)在乳腺浸润性导管癌发展过程中的作用及其临床意义。方法:采用免疫组织化学法检测Hpa在14例乳腺纤维腺瘤和81例乳腺浸润性导管癌中的表达,分析其与乳腺浸润性导管癌临床病理参数的关系。结果:在乳腺浸润性导管癌组中Hpa的阳性表达率为72.96%,显著高于在乳腺纤维腺瘤组中的表达(P<0.005);Hpa表达与肿瘤的组织学分级、肿瘤最大径、PTNM分期、淋巴结转移均有一定关系(P<0.005),而与患者的年龄、月经状况均无明显关系(P>0.05)。结论:Hpa可能促进乳腺浸润性导管癌的生长、浸润和转移,并在一定程度上标志着肿瘤的生物学特征。

       

      Abstract: Objective: To study the role and clinical significance of heparanase(Hpa) in the progress of invasive ductal carcinomas of the breast.Methods: Hpa expression in 14 cases of fibroadenomas and 81 cases of invasive ductal carcinomas of the breast was examined by PV-9000 immunohistochemistry analysis.Its correlation with clinic-pathological parameters in the carcinomas of the breast was also studied.Results: The positive expression ratio of Hpa in the tissues of invasive ductal carcinomas of the breast was 72.96%,which was significantly higher than that in fibroadenomas(P<0.005);Hpa expression was correlated with tumor's size,pTNM stage,histological grade and lymph node metastasis(P<0.005),but was not significantly correlated with patients' menstruation status or age(P>0.05).Conclusions: Hpa may accelerate the growth,invasion and metastasis of carcinomas of the breast.It reflects the biological characteristics of carcinomas of the breast to some degree.

       

    /

    返回文章
    返回